trending Market Intelligence /marketintelligence/en/news-insights/trending/O-9d-KMp20cASE9JzD4Czg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Silence Therapeutics appoints chairman

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Silence Therapeutics appoints chairman

Silence Therapeutics plc appointed Annalisa Jenkins the nonexecutive chairman of the company's board of directors.

Stephen Parker, the company's former nonexecutive chairman, will transition to a nonexecutive director role.

Jenkins is the CEO of Dimension Therapeutics Inc.